| Dr David D Coultas, MD | |
|
1606 W Lafayette Ave, Jacksonville, IL 62650-3707 | |
| (217) 245-1421 | |
| (217) 243-1699 |
| Full Name | Dr David D Coultas |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Location | 1606 W Lafayette Ave, Jacksonville, Illinois |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1902804495 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | (Illinois) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr David D Coultas, MD Po Box 3428, Springfield, IL 62708-3428 Ph: (217) 757-7491 | Dr David D Coultas, MD 1606 W Lafayette Ave, Jacksonville, IL 62650-3707 Ph: (217) 245-1421 |
News Archive
Foundation Medicine, Inc. and collaborators from the University of Texas MD Anderson Cancer Center and Sarah Cannon Research Institute at HealthOne today announced compelling new data demonstrating that matching patients to targeted therapies based on the unique molecular profile of the patient's advanced cancer leads to improved outcomes across a variety of key measures, including overall survival.
According to the National Institute of Health, 40 percent to 45 percent of Americans diagnosed with diabetes already have some stage of diabetic retinopathy. Diabetic retinopathy, damage to the retina caused by leaky blood vessels, is a major cause of blindness in people with diabetes and is one of the most feared diabetic complications. In
Allviant Corporation today announced the launch of its CarePass™ pilot program with Arizona State University to add another tool to the university's health and wellness communications and services while empowering its employees and students with tools to manage their healthcare relationships.
Resverlogix Corp. today announced that it has entered into a Framework Agreement which sets forth the principal business terms for an equity investment and a license of RVX-208, for all indications, to Shenzhen Hepalink Pharmaceutical Co., Ltd. for China, Hong Kong, Taiwan and Macau (the "Territories").
A team of UC Davis investigators has discovered a protein on the surface of lung cancer cells that could prove to be an important new target for anti-cancer therapy. A series of experiments in mice with lung cancer showed that specific targeting of the protein with monoclonal antibodies reduced the size of tumors, lowered the occurrence of metastases and substantially lengthened survival time.
› Verified 7 days ago
Dr. Eli G Goodman, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1600 W Walnut St, Jacksonville, IL 62650 Phone: 217-479-5890 | |
Dr. Edwin Roy Mathews, DO Internal Medicine Medicare: Medicare Enrolled Practice Location: 15 Founders Ln Ste 100, Jacksonville, IL 62650 Phone: 217-243-0300 Fax: 217-245-6775 | |
Dr. Babu Rao Eladasari, MD,FACP Internal Medicine Medicare: Medicare Enrolled Practice Location: 559 N Westgate Ave, Jacksonville, IL 62650 Phone: 217-243-5474 Fax: 217-245-2322 | |
Dr. Thomas Anthony Baker, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 2268 E Morton Ave, Jacksonville, IL 62650 Phone: 217-245-1481 | |
Chandupatla Prabhakar, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 559 N Westgate, Jacksonville, IL 62650 Phone: 217-243-5474 Fax: 217-245-2322 |